GB1495159A - Process reducing the anticomplementary activity of gamma globulins - Google Patents

Process reducing the anticomplementary activity of gamma globulins

Info

Publication number
GB1495159A
GB1495159A GB53020/75A GB5302075A GB1495159A GB 1495159 A GB1495159 A GB 1495159A GB 53020/75 A GB53020/75 A GB 53020/75A GB 5302075 A GB5302075 A GB 5302075A GB 1495159 A GB1495159 A GB 1495159A
Authority
GB
United Kingdom
Prior art keywords
gamma globulin
solution
centrifuged
precipitated
hydroxyethyl starch
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB53020/75A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Plasmesco AG
Original Assignee
Plasmesco AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Plasmesco AG filed Critical Plasmesco AG
Publication of GB1495159A publication Critical patent/GB1495159A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
GB53020/75A 1975-01-02 1975-12-29 Process reducing the anticomplementary activity of gamma globulins Expired GB1495159A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2500076A DE2500076C3 (de) 1975-01-02 1975-01-02 Verfahren zur Gewinnung von intravenös-verträglichen Gammaglobulinen

Publications (1)

Publication Number Publication Date
GB1495159A true GB1495159A (en) 1977-12-14

Family

ID=5935911

Family Applications (1)

Application Number Title Priority Date Filing Date
GB53020/75A Expired GB1495159A (en) 1975-01-02 1975-12-29 Process reducing the anticomplementary activity of gamma globulins

Country Status (20)

Country Link
JP (1) JPS5512001B2 (enrdf_load_stackoverflow)
AT (1) AT344883B (enrdf_load_stackoverflow)
AU (1) AU505416B2 (enrdf_load_stackoverflow)
BE (1) BE837211A (enrdf_load_stackoverflow)
CA (1) CA1058075A (enrdf_load_stackoverflow)
DD (1) DD121875A5 (enrdf_load_stackoverflow)
DE (1) DE2500076C3 (enrdf_load_stackoverflow)
DK (1) DK144679C (enrdf_load_stackoverflow)
EG (1) EG11987A (enrdf_load_stackoverflow)
ES (1) ES443982A1 (enrdf_load_stackoverflow)
FR (1) FR2296429A1 (enrdf_load_stackoverflow)
GB (1) GB1495159A (enrdf_load_stackoverflow)
IE (1) IE43449B1 (enrdf_load_stackoverflow)
IL (1) IL48766A (enrdf_load_stackoverflow)
IN (1) IN143525B (enrdf_load_stackoverflow)
NL (1) NL179824C (enrdf_load_stackoverflow)
PL (1) PL99599B1 (enrdf_load_stackoverflow)
SE (1) SE437470B (enrdf_load_stackoverflow)
SU (1) SU576898A3 (enrdf_load_stackoverflow)
ZA (1) ZA758050B (enrdf_load_stackoverflow)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1980002374A1 (en) * 1979-05-10 1980-11-13 American Hospital Supply Corp Hydroxyalkyl starch drug carrier
EP0073371A3 (en) * 1981-08-24 1983-09-21 Miles Laboratories Inc. Intravenously injectable immune serum globulin and method of preparing same
EP1190719A1 (de) * 2000-08-17 2002-03-27 B. Braun Melsungen Ag Kolloidale Pharmakomodulation injizierter Arzneimittel
US8497072B2 (en) 2005-11-30 2013-07-30 Abbott Laboratories Amyloid-beta globulomer antibodies
US8691224B2 (en) 2005-11-30 2014-04-08 Abbvie Inc. Anti-Aβ globulomer 5F7 antibodies
US8877190B2 (en) 2006-11-30 2014-11-04 Abbvie Inc. Aβ conformer selective anti-Aβ globulomer monoclonal antibodies
US8895004B2 (en) 2007-02-27 2014-11-25 AbbVie Deutschland GmbH & Co. KG Method for the treatment of amyloidoses
US8987419B2 (en) 2010-04-15 2015-03-24 AbbVie Deutschland GmbH & Co. KG Amyloid-beta binding proteins
US9062101B2 (en) 2010-08-14 2015-06-23 AbbVie Deutschland GmbH & Co. KG Amyloid-beta binding proteins
US9176150B2 (en) 2003-01-31 2015-11-03 AbbVie Deutschland GmbH & Co. KG Amyloid beta(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2604759C2 (de) * 1976-02-07 1983-06-01 SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld Verfahren zur Gewinnung von iv-verträglichen Γglobulinen
JPS6016406B2 (ja) * 1976-08-06 1985-04-25 マイヤ−、ル−イス、コ−バル 静脈内に投与可能なガンマ・グロブリンの製造法ならびにそれにより調製したガンマ・グロブリン
US4124576A (en) * 1976-12-03 1978-11-07 Coval M L Method of producing intravenously injectable gamma globulin
GB1603244A (en) * 1977-05-20 1981-11-18 Max Planck Gesellschaft Medicaments for the suppression of pathological processes
JPS5822085B2 (ja) * 1977-07-19 1983-05-06 株式会社ミドリ十字 静注用ガンマ・グロブリン製剤
AT359641B (de) * 1978-09-19 1980-11-25 Immuno Ag Verfahren zur herstellung eines intravenoes ver- abreichbaren antikoerperhaeltigen immunglobulin- praeparates
ATE19735T1 (de) * 1982-02-08 1986-05-15 Schweiz Serum & Impfinst Intravenoes verabreichbares humanes immunglobulin und verfahren zu dessen herstellung.
US4482483A (en) * 1983-04-06 1984-11-13 Armour Pharmceutical Company Composition of intravenous immune globulin
SE8302483L (sv) * 1983-05-02 1984-11-03 Pharmacia Ind Forfarande vid rening av biologiskt aktiva substanser
US5945098A (en) * 1990-02-01 1999-08-31 Baxter International Inc. Stable intravenously-administrable immune globulin preparation
DE19907257A1 (de) * 1999-02-21 2000-09-14 Bernd Horst Meier Mittel zur Steuerung der Diffusion von Injektionslösungen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE348942B (enrdf_load_stackoverflow) * 1970-06-02 1972-09-18 Statens Bakteriologiska Labor
DE2234069A1 (de) * 1971-07-16 1973-02-08 South African Inventions Verfahren zur herstellung eines gereinigten gamma-globulins
ZA738779B (en) * 1972-11-27 1974-10-30 Baxter Laboratories Inc Production of gamma globulin
JPS49101516A (enrdf_load_stackoverflow) * 1973-01-13 1974-09-25

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1980002374A1 (en) * 1979-05-10 1980-11-13 American Hospital Supply Corp Hydroxyalkyl starch drug carrier
EP0028641A4 (en) * 1979-05-10 1981-09-01 American Hospital Supply Corp MEDICINAL PRODUCTS BASED ON HYDROXYALKYL STARCH.
EP0019403A3 (en) * 1979-05-10 1981-10-07 American Hospital Supply Corporation Hydroxyalkyl-starch drug carrier and method of administering a biologically active compound to an animal
EP0073371A3 (en) * 1981-08-24 1983-09-21 Miles Laboratories Inc. Intravenously injectable immune serum globulin and method of preparing same
EP1190719A1 (de) * 2000-08-17 2002-03-27 B. Braun Melsungen Ag Kolloidale Pharmakomodulation injizierter Arzneimittel
US9176150B2 (en) 2003-01-31 2015-11-03 AbbVie Deutschland GmbH & Co. KG Amyloid beta(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof
US10464976B2 (en) 2003-01-31 2019-11-05 AbbVie Deutschland GmbH & Co. KG Amyloid β(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof
US8691224B2 (en) 2005-11-30 2014-04-08 Abbvie Inc. Anti-Aβ globulomer 5F7 antibodies
US10323084B2 (en) 2005-11-30 2019-06-18 Abbvie Inc. Monoclonal antibodies against amyloid beta protein and uses thereof
US10538581B2 (en) 2005-11-30 2020-01-21 Abbvie Inc. Anti-Aβ globulomer 4D10 antibodies
US9540432B2 (en) 2005-11-30 2017-01-10 AbbVie Deutschland GmbH & Co. KG Anti-Aβ globulomer 7C6 antibodies
US8497072B2 (en) 2005-11-30 2013-07-30 Abbott Laboratories Amyloid-beta globulomer antibodies
US10208109B2 (en) 2005-11-30 2019-02-19 Abbvie Inc. Monoclonal antibodies against amyloid beta protein and uses thereof
US9359430B2 (en) 2006-11-30 2016-06-07 Abbvie Inc. Abeta conformer selective anti-Abeta globulomer monoclonal antibodies
US9394360B2 (en) 2006-11-30 2016-07-19 Abbvie Inc. Aβ conformer selective anti-Aβ globulomer monoclonal antibodies
US9951125B2 (en) 2006-11-30 2018-04-24 Abbvie Inc. Aβ conformer selective anti-Aβ globulomer monoclonal antibodies
US8877190B2 (en) 2006-11-30 2014-11-04 Abbvie Inc. Aβ conformer selective anti-Aβ globulomer monoclonal antibodies
US8895004B2 (en) 2007-02-27 2014-11-25 AbbVie Deutschland GmbH & Co. KG Method for the treatment of amyloidoses
US9822171B2 (en) 2010-04-15 2017-11-21 AbbVie Deutschland GmbH & Co. KG Amyloid-beta binding proteins
US8987419B2 (en) 2010-04-15 2015-03-24 AbbVie Deutschland GmbH & Co. KG Amyloid-beta binding proteins
US10047121B2 (en) 2010-08-14 2018-08-14 AbbVie Deutschland GmbH & Co. KG Amyloid-beta binding proteins
US9062101B2 (en) 2010-08-14 2015-06-23 AbbVie Deutschland GmbH & Co. KG Amyloid-beta binding proteins

Also Published As

Publication number Publication date
DK144679B (da) 1982-05-10
DK144679C (da) 1982-10-11
FR2296429A1 (fr) 1976-07-30
FR2296429B1 (enrdf_load_stackoverflow) 1978-12-01
BE837211A (fr) 1976-06-30
AU505416B2 (en) 1979-11-22
NL179824C (nl) 1986-11-17
IN143525B (enrdf_load_stackoverflow) 1977-12-17
ES443982A1 (es) 1977-07-16
PL99599B1 (pl) 1978-07-31
NL7514627A (nl) 1976-07-06
IE43449L (en) 1976-07-02
SE7514388L (sv) 1976-07-05
NL179824B (nl) 1986-06-16
DE2500076B2 (de) 1979-02-22
IE43449B1 (en) 1981-02-25
EG11987A (en) 1981-12-31
JPS5191321A (en) 1976-08-10
JPS5512001B2 (en) 1980-03-29
SE437470B (sv) 1985-03-04
ZA758050B (en) 1976-12-29
AT344883B (de) 1978-08-10
AU8792175A (en) 1977-07-14
CA1058075A (en) 1979-07-10
IL48766A0 (en) 1976-02-29
ATA981675A (de) 1977-12-15
DD121875A5 (enrdf_load_stackoverflow) 1976-09-05
DE2500076A1 (de) 1976-07-08
DK584375A (da) 1976-07-03
SU576898A3 (ru) 1977-10-15
IL48766A (en) 1979-11-30
DE2500076C3 (de) 1982-11-18

Similar Documents

Publication Publication Date Title
GB1495159A (en) Process reducing the anticomplementary activity of gamma globulins
Chazotte et al. Further studies on F1-ATPase inhibition by local anesthetics
ES8506758A1 (es) Un procedimiento para preparar un compuesto de oclusion de 2-nitroximetil-6-cloropiridina
FI844557L (fi) Koncentrat av antihemofilfaktorn viii och foerfarande foer framstaellning av detsamma.
GB1480700A (en) Rifamycin s and sv derivatives
GB1418849A (en) Production of antisera
GB1034186A (en) Process for isolating ª‡-antitrypsin from human or animal body fluids
GB779493A (en) Process for the isolation of stable, highly purified gamma globulin preparations
GB1528259A (en) Process for the preparation of a gamma-globulin solution suitable for intravenous administration
IE42521L (en) Treating a sodium lauryl sulphate-whey protein complex.
GB1436529A (en) Process for preparing a blood fraction
GB1443692A (en) 1,2-diphenylethanolamine derivatives and their salts and the preparation thereof
GB1529576A (en) Derivatives of diphtheria toxin process for preparing them and agents containing them
GB1469908A (en) Preparation containing an enzyme for removal of anti-complement from gamma globulin
DE3483784D1 (de) Verfahren zur herstellung von gamma-globulin zur intravenoesen anwendung.
GB1441752A (en) Preparation of human or other purified albumin
GB1253328A (en) PURIFICATION OF gamma GLOBULIN
KR900007836A (ko) 티아졸 유도체
IE34609L (en) Therapeutic substituted thiazolidinedione
GB1291442A (en) Adamantylamino-5,8-dihydronaphthyloxy-propanols and related compounds
GB967594A (en) 2-(2,6-dimethyl-3-hydroxy-4-tert-butyl-benzyl)-2-imidazoline,and acid addition salts thereof,and process for their manufacture
GB1312392A (en) Basically substituted 4 3h-quinazolinone derivatives and process for their manufacture
GB1441625A (en) Method of extracting pure serum albumin from serum
GB1384684A (en) 1,3,5-triazine and process for the preparation thereof
Lewis et al. Erythropoietic Activity in Human Urine Concentrate.

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PE20 Patent expired after termination of 20 years

Effective date: 19951228